Figure 2.
Schematic representation of the interactions of HLA-G with CTLA-4/TIM-3 and their ligands. Possible effects of the administration of anti-CTLA-4 and/or anti-TIM-3 in combination with anti-HLA-G blocking antibodies are also shown.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.